Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.46 |
| ▸ | DRD5 | P21918 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28817472 | 0.82 | PTGS1 (0.46) | HPGDSMN1; SMN2RAB9AL3MBTL1POLB | |
| SCHEMBL45228 | 0.80 | LMNA (0.50) | HPGDSMN1; SMN2RAB9AL3MBTL1POLB | |
| SCHEMBL6076332 | 0.80 | LTA4H (0.44) | RAB9AL3MBTL1POLBPTGS1PTGS2 | |
| SCHEMBL10525378 | 0.79 | L3MBTL1 (0.55) | L3MBTL1PTGS1PTGS2DRD4LMNA | |
| SCHEMBL20738474 | 0.79 | MEN1 (0.61) | HPGDSMN1; SMN2RAB9ATP53POLB | |
| SCHEMBL3238290 | 0.79 | LMNA (0.62) | HPGDSMN1; SMN2L3MBTL1POLBSLC6A3 | |
| SCHEMBL7294757 | 0.79 | CYP3A4 (0.52) | HPGDL3MBTL1POLBPTGS1PTGS2 | |
| SCHEMBL10953000 | 0.79 | HPGD (0.46) | HPGDPOLBPTGS1PTGS2LMNA | |
| SCHEMBL11660485 | 0.79 | TAAR1 (0.42) | L3MBTL1PTGS1PTGS2LMNATAAR1 | |
| SCHEMBL3385419 | 0.79 | MEN1 (0.54) | HPGDSMN1; SMN2RAB9ATP53POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119876994-A | Copper-based electrocatalytic material and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119096372-A | Photovoltaic device and method of manufacture | 第一阳光公司 | 2024-12-06 | — | — | CN | claimed |
| CN-116918029-A | selective thermal atomic layer deposition | 弗萨姆材料美国有限责任公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116761906-A | Selective plasma enhanced atomic layer deposition | 弗萨姆材料美国有限责任公司 | 2023-09-15 | — | — | CN | claimed |
| CN-116583623-A | Selective deposition of silicon and oxygen containing dielectric films on dielectrics | 弗萨姆材料美国有限责任公司 | 2023-08-11 | — | — | CN | claimed |
| CN-110192294-B | Lithium electrode and lithium secondary battery comprising same | 株式会社LG新能源 | 2022-09-20 | — | — | CN | claimed |
| CN-111033864-B | Electrolyte for lithium metal battery and lithium metal battery comprising same | 株式会社LG新能源 | 2022-08-12 | — | — | CN | claimed |
| US-20070117775-A1 | Compositions and Methods For Treating Inflammatory Disorders | RIGEL PHARMACEUTICALS, INC. (US) | 2007-05-24 | — | — | US | claimed |
| EP-0719771-A1 | Process for the preparation of methylene compounds and the compound 2-(2',4'-dichloro-5'-fluorobenzyl)-thiophene | BAYER AG (DE) | 1996-07-03 | — | — | EP | claimed |
| CN-120201999-A | Antimicrobial compositions | AHV国际有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-115724882-B | Phosphorothioates method for synthesizing compound | 南通大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-119096372-A | Photovoltaic device and method of manufacture | 第一阳光公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-117466790-B | Preparation method of alpha-sulfinylated carbonyl compound | 西北师范大学 | 2024-05-28 | — | — | CN | disclosed |
| CN-114945627-B | Cation-exchange and anion-exchange polymers and blend membranes prepared from fluorinated aromatic group-containing polymers by nucleophilic substitution | 斯图加特大学 | 2024-05-24 | — | — | CN | disclosed |
| EP-0667855-A4 | SUBSTITUTED ARYLALKYNYL- AND HETEROARYLALKYNYL-N-HYDROXYUREA INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS. | ABBOTT LAB (US) | 1996-02-21 | — | — | EP | disclosed |
| WO-1995030671-A1 | SUBSTITUTED ARYL- AND HETEROARYLALKENYL-N-HYDROXYUREA INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS | ABBOTT LABORATORIES (US) | 1995-11-16 | — | — | WO | disclosed |
| EP-0667855-A1 | SUBSTITUTED ARYLALKYNYL- AND HETEROARYLALKYNYL-N-HYDROXYUREA INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS | ABBOTT LABORATORIES (US) | 1995-08-23 | — | — | EP | disclosed |
| WO-1995012589-A1 | PROCESS FOR THE PREPARATION OF N-4-[(SUBSTITUTED PHENYL)ALKYLTHIENYL]-, AND N-4-[(SUBSTITUTED PHENYL)ALKYLFURYL]BUT-3-YN-2-YL]-N-HYDROXYUREA COMPOUNDS | ABBOTT LABORATORIES (US) | 1995-05-11 | — | — | WO | disclosed |
| WO-1994011342-A1 | SUBSTITUTED ARYLALKYNYL- AND HETEROARYLALKYNYL-N-HYDROXYUREA INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS | ABBOTT LABORATORIES (US) | 1994-05-26 | — | — | WO | disclosed |
| US-5288751-A | [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis | ABBOTT LABORATORIES (US) | 1994-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070117775-A1 | Compositions and Methods For Treating Inflammatory Disorders | SYK, IRAK2, IRAK4 | HPGD 1967/4885SMN1; SMN2 2396/4885RAB9A 3961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.